gastroparesis and glp 1 drugs Lawsuits involving popular GLP-1 medications such as Ozempic, Wegovy, Mounjaro continue to grow as patients report serious side effects, including gastroparesis, severe gastrointestinal complications, and NAION vision loss. These medications, widely GLP-1 Receptor Agonists and Gastrointestinal
Description
Phase 3 TRIUMPH-4 demonstrated 28.7% mean weight loss at 68 weeks with the 12 mg dose, confirming the exceptional Phase 2 results (24.2% at 48 weeks
[DOI] [PMC free article] [PubMed] [Google Scholar] 293.Engelstoft M.S., Schwartz T.W
Patients using GLP-1 medications had twice the risk of developing vision-threatening nAMD compared with those not taking these drugs
7/3/23 2 Yahoo Finance
Eisenberg oversaw the project, providing critical feedback and revisions to the manuscript
